Will I Put Weight Back On After Stopping Mounjaro?

What the trial data actually shows about weight regain

The SURMOUNT-1 trial, published in the New England Journal of Medicine, followed thousands of adults taking tirzepatide for 72 weeks. At the highest dose, participants lost an average of around 20–21% of their body weight. That result attracted a lot of attention. Less widely reported is what happens in extension and withdrawal studies of medicines in this class.

Research into GLP-1 receptor agonists consistently shows that weight regain begins relatively quickly after the medicine is stopped, in semaglutide's STEP 4 withdrawal trial, roughly two-thirds of the weight lost was regained within a year of stopping. Tirzepatide, as a dual GIP and GLP-1 receptor agonist, produces larger average losses, but the biological mechanism driving regain is the same: the medicine suppresses appetite by mimicking gut hormones, and once you stop, those hormones return to their previous levels. Hunger comes back. Calorie intake rises. The body, which is biologically primed to defend a higher set-point, responds accordingly.

This is not a failure on anyone's part. It reflects how appetite and weight regulation actually work, which is why bodies like NICE, in its appraisal of tirzepatide (TA1026), treat weight management as an ongoing clinical consideration rather than a fixed course of treatment.

Why some people regain more than others

Not everyone regains at the same rate, and this is one of the most practically useful things to understand. Several factors seem to matter.

How much time someone spent building new habits during treatment makes a meaningful difference. Mounjaro quietens the appetite signals that make changing eating patterns so difficult. People who use that window to establish sustainable routines (eating adequate protein, staying active, managing stress) tend to maintain more of their progress than those who relied on appetite suppression alone. That is not a moral judgement; it is just what the data suggests.

Starting weight and how much was lost also play a role. Larger absolute losses tend to come with more regain in absolute terms, even when the percentage held onto is similar. And individual metabolic factors, health conditions and whether someone continues to receive professional support all influence the picture.

The honest framing is that whether you put weight back on after Mounjaro depends considerably on stopping with a clinical review, a realistic maintenance strategy and ongoing support, rather than stopping without any plan, which is the highest-risk option.

Does this mean Mounjaro is only worth taking long-term?

Not necessarily. A prescriber might recommend a defined course if your goal is to reach a healthier weight ahead of surgery, during a specific health episode, or as a bridge while building the habits that will carry you forward. There are legitimate reasons to take it for a finite period.

For others, especially those with significant weight-related health conditions, the clinical case for continuing is strong. The NHS patient information for tirzepatide does not set a maximum duration in the way some other medicines do. Ongoing treatment is reviewed against clinical need. If you are thinking about whether to continue, that is exactly the kind of decision to make with your prescriber rather than by reading your own prescription label.

If the prospect of long-term treatment gives you pause (financially, practically, or because you are not sure it is still working) that is worth raising. Many people find that a lower maintenance dose is sufficient once the majority of weight has been lost, though any change to dose or duration is for your prescriber to advise on. You can read more about how weight loss on Mounjaro tends to progress for context on what the treatment period itself looks like.

Planning ahead: what actually helps

This question comes up a lot, and the people asking it are usually not looking for bad news. They are trying to figure out whether the effort and cost are worth it, and whether there is anything they can do to protect what they have worked for. That is a completely reasonable thing to want to know.

The evidence points to a few practical things. Strength training and protein intake both support muscle preservation during weight loss, which matters for long-term metabolic health. Understanding what happens to your weight when you stop Mounjaro can help you and your prescriber decide whether gradual tapering, where clinically appropriate, may give the body more time to adjust than an abrupt stop. Keeping a regular check on weight after stopping (not obsessively, but deliberately) allows early intervention if things shift significantly.

Professional support matters too. People who continue with dietitian input, GP monitoring or a clinical aftercare programme after stopping tend to do better, and research into whether people put weight back on after Mounjaro consistently points to ongoing professional support as one of the factors that makes the biggest difference. If you want to explore what treatment through a registered UK pharmacy looks like, including clinical oversight throughout, our treatment overview page explains the process in full. For background on tirzepatide's mechanism and evidence base, that is a good starting point before a consultation.

At nume, every repeat prescription includes a clinical review by a GPhC-registered prescriber, not a form, not a system. A real clinician reads your case. That means if your needs or circumstances change, the treatment plan can change too, and if you have questions about putting weight back on after stopping Mounjaro, your prescriber can discuss the evidence and what it means for your specific situation.

If you are ready to talk through your options, start your free consultation and our prescribers will review your case the same day.